Research Acknowledgment & Age Verification
Access to our peptide portfolio is reserved for individuals of legal age acquiring products for laboratory research.
Nicotinamide Riboside (NR) chloride is a specialized pyridine-nucleoside precursor utilized by cellular nicotinamide riboside kinases (NRK1/2) to phosphorylate directly into NMN and downstream NAD+. In comparative metabolic kinetics assays, NR avoids the rate-limiting feedback inhibition associated with NAMPT, offering high-efficiency replenishment of nuclear and mitochondrial NAD+ compartments. Purity validated at ≥99.0% by HPLC. Strictly for laboratory research.
Chemical & Analytical Specifications
Laboratory Handling & Solvent Protocols
To preserve structural integrity and peptide purity, lyophilized materials should be maintained at -20°C in an airtight container protected from ambient moisture and light. Reconstitution should be conducted under sterile conditions using bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory saline. Allow the diluent to run gently down the interior vial wall; avoid vigorous shaking or vortexing to prevent shear-induced degradation. Reconstituted aliquots must be stored at 2°C to 8°C and evaluated within 28 to 30 days.
Nicotinamide Riboside (NR Chloride)
Research Pathways & Profile
Analytical Specifications & Sequence
Handling, Solvent & Storage Guidelines
1All peptide compounds cataloged are intended exclusively for laboratory research, biochemical assays, and analytical characterization. Strictly not for human, veterinary, diagnostic, or therapeutic administration.
2Analytical purity (≥99%) is validated via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Compound integrity is dependent on adherence to cold-chain storage and inert handling protocols.
3The acquiring entity assumes sole responsibility for regulatory compliance, laboratory safety protocols, and safe handling in accordance with federal, state, and local standards. èvelan expressly disclaims liability for off-label or unapproved application.
View Full Legal & Research Disclaimer →



